Pedersen, Louise Rasmussen and Maggie Fick COPENHAGEN (Reuters) -Denmark's Novo Nordisk launched a rival bid for U. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer as the ...

Alix Earle’s stepmom Ashley Dupré drew backlash after telling DWTS guest judge Cheryl Burke to 'take more Ozempic' following ...

According to new survey data from Gallup, for the first time in years, there’s a significant drop in obesity rates. The percentage of obese Americans has apparently dropped from 39.9% in 2022 to 37% ...

Lilly said Thursday that its top-selling drugs, Mounjaro and Zepbound, brought in more than $10 billion combined during the ...

A woman has taken to the internet to share the biggest difference she experienced when switching between GLP-1 drugs Wegovy ...

Dupré shared her reaction to Earle’s latest DWTS performance via TikTok, cheering when she got 10s from the judges. When ...

Rising food prices remain the top concern among consumers globally, according to a recent study. Food inflation ranked higher ...

This article was reviewed by Lynn Marie Morski, MD, JD. How Long Does Ozempic® Stay in Your System? Key takeaways: Ozempic® ...

Novo Nordisk launched a bid valued at up to $9 billion for obesity-drug developer Metsera, hoping to trump an already agreed-on deal Pfizer made for the U.S. company last month.

Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited ...

This article was reviewed by Lynn Marie Morski, MD, JD. Does Ozempic® Cause Cancer? Key takeaways: Semaglutide — the active ...

The Wegovy and Ozempic maker’s offer comes after Pfizer last month agreed to a lower deal to acquire the Nasdaq-listed ...